Chengdu Guojia United Pharmaceutical

Chengdu Guojia United Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, manufacture, and commercialization of both Western chemical drugs and Traditional Chinese Medicine (TCM) formulations. Established in 1996, the company operates as a core subsidiary of Singapore-listed Pharmesis International Ltd. Its flagship Western medicine product is Anethol Trithione (marketed under the brand name Danweita or Kinna), which is widely used in China for treating cholecystitis, gallstones, and hepatitis by promoting bile secretion and increasing intracellular glutathione levels. Additionally, the company produces several proprietary TCM products, including Shuling throat tablets, Xiaoshi Jianpi tablets, and Xiongdan Chuanbei oral liquid, targeting respiratory, digestive, and hepatobiliary indications.